Erythromycin
Regulatory activity · MHRAAlso known as Abomacetin, Aktipak, E-Solve 2, E.E.S.+48 more
Abomacetin, Aktipak, E-Solve 2, E.E.S., Emcin Clear, Emgel, Eritromicina, Ery, Ery-Sol, Ery-Tab, EryPed, Eryc, Erycette, Eryderm, Erygel, Erymax, Erythra-Derm, Erythrocin Stearate, Erythrocot, Erythromycin Base, Erythromycin Estolate, Erythromycin Lactobionate, Erythromycin Stearate, Erythromycin Topical, Erythromycin, Ophthalmic, Eryzole, Ilosone, Ilotycin, MY-E, Maracyn, Staticin, T-Stat, 3''-O-demethylerythromycin, Akne-Mycin, Benzamycin, Benzoyl Peroxide-Erythromycin, Del-Mycin, E-Mycin, Erythromycin-Sulfisoxazole, Eyemycin, Pediazole, Robimycin, Romycin, Sulfimycin, Theramycin, Erythrocin, Erythromycin A, Erythromycin ES, érythromycine, A/T/S, Erythromycin Ethylsuccinate, Erythromycinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy
Platform for Adaptive Trials in Perinatal Units (Core Protocol)
Comparison of the Effect of Metoclopramide Versus Erythromycin on Gastric Residual Volume
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- Nature communications1
- Bentley SD1
- Chochua S1
- Cohen C1
- de Gouveia L1
- du Plessis M1
- Ferreira ADS1
- Gladstone RA1
- Hawkins PA1
- Centers for Disease Control and Prevention1
- Centre for Respiratory Diseases and Meningitis1
- Milner Centre for Evolution1
- National Institute for Communicable Diseases1
- School of Electrical & Information Engineering1
- School of Pathology1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Erythromycin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.